• USFDA clears Indoco’s Goa Plant II and III expresspharma
    July 30, 2019
    Indoco Remedies has announced that it has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for their sterile facility (Plant II) and solid dosages facility (Plant III) at Verna, Goa.
PharmaSources Customer Service